List details
Basic info
Status | Opinion Adopted |
---|---|
Submitter | Sweden |
Submitter email | kemi@kemi.se |
Regulatory programme |
|
ATP number and date | ATP18 - (16/02/2022), 23/11/2023 |
Link to ATP |
|
Classification
Proposed harmonised classification by the dossier submitter |
|
---|---|
Hazard classes open for commenting | All hazard classes (physical hazards as well as hazards to human health and the environment) with the exception of respiratory sensitisation, aspiration hazard and/or hazardous to the ozone layer (unless the DS provides data for these hazard classes at resubmission) |
Proposed specific concentration limits by the dossier submitter | oral: ATE = 500 mg/kg bw |
Intention timeline
Submitted for accordance check | 2018-05-16 |
---|---|
Final submission date | 2019-05-15 |
Start of consultation | 2019-06-17 |
Deadline for commenting | 2019-08-16 |
Date of opinion | 2020-09-17 |
Legal deadline for opinion adoption | 2020-11-13 |
Documents
CLH report |
|
---|---|
Annexes to the CLH Report |
|
Comments received |
|
RAC opinion |
|
Background document |
|
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
- There are no related (i.e. sharing the same name or identifier) regulatory records in our database
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
This version
Jan. 18, 2023
- ATP number and date: ATP18 - (16/02/2022), 23/11/2023
- Link to ATP / File Title: Official Journal
- Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0692&qid=1667995782196
April 9, 2021
- Name: Quinoclamine → 2-amino-3-chloro-1,4-naphthoquinone
March 27, 2021
- Name: 2-amino-3-chloro-1,4-naphthoquinone → Quinoclamine
Dec. 14, 2020
- Comments received: https://echa.europa.eu/documents/10162/d6310288-1692-77a5-844c-c4ed01a10217
Dec. 8, 2020
- Proposed specific concentration limits by the dossier submitter: oral: ATE = 500 mg/kg bw
- Status: Opinion Development → Opinion Adopted
Dec. 7, 2020
- Background document: https://echa.europa.eu/documents/10162/3a0d965d-3e54-39be-4ff6-5b7ad2683e7c
- Comments received: https://echa.europa.eu/documents/10162/18543927-2654-f910-5240-33e373f3f65c
- RAC opinion: https://echa.europa.eu/documents/10162/b78953d3-1e9c-9936-d34a-fc47be866f8b
Sept. 30, 2020
- Date of opinion: 2020-09-17
July 28, 2020
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/1275408b-224b-7403-a961-e7e04d59a559 → https://echa.europa.eu/documents/10162/906d16e5-f789-043c-0d8c-2a19a8749e7b
- CLH report: https://echa.europa.eu/documents/10162/7cf14961-98c1-eb9e-ed78-bce8e57a4d1e → https://echa.europa.eu/documents/10162/ce234217-39f7-857a-2b54-20368c5a32a2
- Comments received: https://echa.europa.eu/documents/10162/ee1b13dd-2cf7-daaf-966d-d490efc291bb → https://echa.europa.eu/documents/10162/d6310288-1692-77a5-844c-c4ed01a10217
March 12, 2020
- Submitter email: kemi@kemi.se
Aug. 27, 2019
- Comments received: https://echa.europa.eu/documents/10162/ee1b13dd-2cf7-daaf-966d-d490efc291bb
- Status: Public Consultation → Opinion Development
June 18, 2019
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/1275408b-224b-7403-a961-e7e04d59a559
- CLH report: https://echa.europa.eu/documents/10162/7cf14961-98c1-eb9e-ed78-bce8e57a4d1e
- Deadline for commenting: 2019-08-16
- Final submission date: 2019-05-15
- Hazard classes open for commenting: All hazard classes (physical hazards as well as hazards to human health and the environment) with the exception of respiratory sensitisation, aspiration hazard and/or hazardous to the ozone layer (unless the DS provides data for these hazard classes at resubmission)
- Legal deadline for opinion adoption: 2020-11-13
- Proposed harmonised classification by the dossier submitter: Aquatic Acute 1, M-factor=10
- Status: Submitted → Public Consultation
- Start of consultation: 2019-06-17
April 4, 2019
- Regulatory programme: PPP → Active substance in Plant Protection Products
Feb. 18, 2019
- Regulatory programme: Active substance in Plant Protection Products under the Annex I Renewal (AIR) process (Regulation (EC) No. 1141/2010 or Regulation (EC) No. 844/2012) → PPP
- Submitter email: kemi@kemi.se
Add the related substance to your watchlist to monitor this regulatory record.